Despite all that is known about cognitive impairment in multiple sclerosis (MS) and its impact on individuals with MS and their families, cognitive function is still not openly discussed, routinely assessed, or optimally treated. Ample evidence supports early and ongoing cognitive assessment and personalised treatment.
Cognitive impairment is one of the most common and debilitating symptoms in MS, affecting approximately 50% of the patients. Cognitive deficits have a significant impact on patients’ quality of life, particularly at the professional and social levels. They also have an important prognostic value that justifies their early detection.
The summer school will gather international experts in the field to provide an updated and comprehensive review of the field. It will address physiopathology, assessment by neuropsychological tests and ecological evaluation, risk factors, structural and functional imaging correlates of cognitive deficits, neuroplasticity, behavioural problems, pharmacological and behavioural treatments, cognition in pediatric MS, and impact on daily life.
Beyond a theory-led course, participants will be given opportunities to apply the concepts via practical and interactive activities integrated throughout the course and specifically during practical sessions on the second day of the course, dedicated to interactive sessions through four working groups.
The target audience is represented by young neurologists, neuropsychologists, psychiatrists, speech/ language pathologists, occupational therapists, neuroradiologists with interest in this area and basic knowledge of neuropsychology, who want to deepen and implement their expertise in the field.